3i Group plc Interim report 2005

Section content

Portfolio analysis

The Group's equity, fixed income and loan investments total £4,389 million at 30 September 2005 (excluding co-investment funds and joint ventures).
Portfolio value by business line (£m) At 30 September
2005
 
At 31 March
2005
(as restated)*
Buyouts 1,665 1,521
Growth Capital 1,321 1,292
Venture Capital 740 748
SMI 663 756
Total 4,389 4,317
 
Portfolio value by geography (£m)
UK 2,178 2,258
Continental Europe 1,843 1,693
US 262 277
Asia 106 89
Total 4,389 4,317
 
Continental European portfolio value (£m)
Benelux 157 180
France 254 292
Germany/Austria/Switzerland 540 503
Italy 149 69
Nordic 394 344
Spain 282 249
Other European 67 56
Total 1,843 1,693
Other European includes investments in countries where 3i did not have an office at the period end.
 
Portfolio value by FTSE industrial classification (£m)
Resources 152 162
Industrials 1,230 1,077
Consumer goods 991 969
Services and utilities 1,266 1,214
Financials 228 326
Information technology 522 569
Total 4,389 4,317
 
Portfolio value by valuation method (£m)
Imminent sale or IPO 281 373
Listed 216 198
Secondary market 44 37
Earnings 1,155 1,138
Cost 605 468
Further advance 162 203
Net assets 96 92
Other (including other Venture Capital assets valued below cost) 326 408
Loan investments and fixed income shares 1,504 1,400
Total 4,389 4,317
 
Buyout portfolio value by valuation method (£m)
Imminent sale or IPO 96 134
Listed 56 48
Secondary market 1 1
Earnings 358 372
Cost 131 71
Net assets 4 4
Other 78 22
Loan investments and fixed income shares 941 869
Total 1,665 1,521
 
Growth Capital portfolio value by valuation method (£m)
Imminent sale or IPO 136 120
Listed 31 62
Secondary market 24 9
Earnings 395 360
Cost 220 159
Further advance 8 14
Net assets 28 33
Other 79 200
Loan investments and fixed income shares 400 335
Total 1,321 1,292
 
Venture Capital portfolio value by valuation method (£m)
Imminent sale or IPO 17 33
Listed 121 72
Secondary market 15 22
Earnings 5 25
Cost 248 221
Further advance 151 186
Net assets 1 1
Other Venture Capital assets valued below cost 76 71
Other 45 55
Loan investments and fixed income shares 61 62
Total 740 748
- of which early stage Venture Capital 622 561
 
SMI portfolio value by valuation method (£m)
Imminent sale or IPO 32 86
Listed 8 16
Secondary market 4 5
Earnings 397 381
Cost 6 17
Further advance 3 3
Net assets 63 54
Other 48 60
Loan investments and fixed income shares 102 134
Total 663 756
 
Venture Capital portfolio value by sector (£m)
Healthcare 238 228
Communications 162 189
Electronics, semiconductors and advanced technologies 130 141
Software 210 190
Total 740 748
* As restated for the adoption of IFRS, as explained within the Basis of preparation.

Back to top